Application of an Experimentally Flexible Label-Free Quantitative Phosphoproteomic Strategy to Characterize Signaling Pathways within Human Red Blood Cell Membranes.
Erik J. Soderblom, et al.
Duke Proteomics Core Facility
Conference PresentationsConference Presentations
Association for Biomolecular Resource Facilities (ABRF) 2012 [Orlando, FL]
Robust, Quantitative Label-Free Phosphoproteomics Platform: Automated Enrichment and 2D-LC/MS/MS
Brenna M. Richardson, et al.
Comprehensive Strategies for Incorporating Modern Methods for Post-Translational Modification Enrichment and Quantitation in a High-Throughput Research Environment
J. Will Thompson, et al.
Sanibel Conference (ASMS) - Mass Spectrometry Technologies for Structural Biology 2012 [St. Pete Beach, FL]
A Mass Spectrometry-based Carboxyl Footprinting Enrichment Strategy for Detection of Low Abundant Derivatized Peptides.
Erik J. Soderblom, et. al.
American Society for Mass Spectrometry (ASMS) 2011 [Denver, CO]
Automated Quantitative Phosphopeptide Enrichment using Titania-packed Capillary Columns and Its Application to Human Tissues for Label-Free Phosphoproteomics.
Brenna M. Richardson, et al.
Differential Expression Proteomic Phenotyping of Enhanced Survivability of Bacillus pumilus following 18-Month Extraterrestrial Exposure aboard the International Space Station.
M. Arthur Moseley, et al.
Establishing Quality Control Metrics for Immunodepletion of High-Abundance Plasma Proteins and Applying to a Large Clinical Cohort.
Meredith Turner, et al.
Ion Mobility-Assisted Data Independent Analysis with Inter-Analysis Alignment Privides Improved Depth of Proteome Coverage.
J. Will Thompson, et al.
Predicting Treatment-Response for HCV Therapy: Successful Translation from Discovery LC/MSE to Verification LC/MRM.
Laura G. Dubois, et al.
Association for Biomolecular Resource Facilities (ABRF) 2011 [San Antonio, TX]
Development of a Label-Free Quantitative Phosphoproteomics Platform Applicable to Non-Cell Culture Biological Matrices.
Erik J. Soderblom, et. al.
Comprehensive Biomarker Discovery Platform Reveals Qualified MRM Assay for Prediction of INF/Ribavirin Treatment Response in Hepatitis C Patients.
J. Will Thompson, et. al.
© 2004-2012, Duke Institute for Genome Sciences & Policy. Duke University | Duke Medicine | Interdisciplinary Studies at Duke